Hypoglycaemia may be defined as a blood glucose concentration of less than 2-2 mmol/l. In neonates it is usually transient and responds readily to additional enteral intake of glucose or in more refractory cases to intravenous glucose infusion. Severe intractable hypoglycaemia is rare and more difficult to manage. Delay in recognising the problem and starting treatment exposes the infant to the risk of mental retardation.
In patients with persistent hypoglycaemia it is important to exclude other endocrine disorders, for example hypopituitarism, or inborn errors of metabolism, for example glycogen storage disease. Hyperinsulinism accounts for approximately 1% of all cases with hypoglycaemia,' but it is the most common cause of persistent neonatal hypoglycaemia. Laidlaw in 1938, coined the term 'nesidioblastosis' (from Greek 'island') to describe the budding of islet cells from the pancreatic ducts. 2 The specific histological findings in infants with intractable hypoglycaemia were first described by Yakovac et al in 1971 . 3 The pancreatic tissue shows diffuse r) cell and islet cell hyperplasia that is associated with fetal type budding from the pancreatic ducts and disruption of cell ratios and cell to cell contact within the exocrine pancreas. 4 The diagnosis of hyperinsulinism is made on the following criteria':
(1) Inappropriately raised plasma insulin concentrations for blood glucose values. (2) Glucose infusion rate >10 mg/kg/minute needed to maintain a blood glucose concentration >2 mmol/l (in the absence of glycosuria).
(3) Low plasma free fatty acids and blood ketone bodies during hypoglycaemia. (4) A glycaemic response to glucagon despite hypoglycaemia. The condition is inherited as an autosomal recessive.6`0 It has been described in association with familial multiple endocrine adenomatosis" and been implicated in sudden infant death syndrome. [12] [13] [14] Medical treatment consists of providing sufficient glucose to prevent the hypoglycaemia, which usually requires an intravenous infusion of 15-20% glucose. Diazoxide is still the mainstay of the medical management. It inhibits glucose stimulated insulin secretion and doses of up to 20 mg/kg body weight/day may be necessary. Its action is potentiated by the diuretic chlorothiazide. Somatostatin inhibits insulin release and this hormone or one of its analogues is a useful short term therapeutic adjunct in the preoperative preparation of the infant with refractory hyperinsulinism. l Tolerance may develop'6 and surgical treatment is indicated if the patient remains dependent on intravenous glucose.
Patients not responding to optimal medical treatment should be offered surgery at an early stage and not as a last resort. The results of surgery vary according to the extent of the pancreatic resection. The recurrence rate is unacceptably high when the resection is conservative (75-80% pancreatectomy), whereas total pancreatectomy inevitably leads to permanent diabetes and exocrine deficiency. A 95% resection produces the best overall results. 17
Patients and methods

PATIENTS
In the eight year period, 1982-90, 21 infants and children with severe persistent hypoglycaemia unresponsive to medical treatment were referred for surgical treatment. There were 11 boys and 10 girls whose ages ranged from 8 days to 5 years ( fig 1) and birth weights ranged from 2680 to 6800 g. Seventeen (80%) of the infants presented with central nervous system manifestations in the form of twitchings, tremors, limpness, or irritability with or without convulsions within the first three days of life. In three patients who had already had clear evidence of mental retardation presentation was delayed for between 7-24 weeks.
The diagnosis of hyperinsulinism was made according to strict biochemical criteria. Inappropriately high concentrations of plasma insulin were recorded during episodes of hypoglycaemia in all patients (fig 2) . Plasma insulin concentrations ranged from 8-4 to 86 mU/l with a mean of 27-1 mU/l (60-3 to 617-1 pmol/l, mean 19414 pmol/l).
Diagnostic imaging, including ultrasound scan, computed tomography in most patients, selective coeliac angiography in two, and high resolution magnetic resonance imaging in one patient were singularly unhelpful.
All patients had hepatomegaly, which was considerable in seven infants. Three patients had moderate hypertension and three developed clinical cardiac failure secondary to large volumes of glucose solutions required to achieve normoglycaemia in combination with high doses of diazoxide. Somatostatin was used preoperatively in two patients as a short term measure to control the hypoglycaemia.
Surgery was undertaken as soon as it became evident that the patient could not be maintained on medical treatment alone.
OPERATIVE PROCEDURE
Via a generous upper abdominal transverse muscle-cutting incision, a thorough laparotomy was carried out in search of ectopic pancreatic tissue. The entire pancreas was carefully exposed and examined for the presence of an adenoma, which when present appeared as a reddishbrown nodule on the surface of the greyish pancreas. These lesions were excised and submitted for frozen section histological examination, but because of the coexistence of adenoma and nesidioblastosis particularly in infancy, a full 95% pancreatectomy was carried out. The tail of the pancreas was carefully dissected off the hilum of the spleen and the body of the pancreas mobilised by meticulously exposing and ligating the numerous short pancreatic vessels arising from the splenic vessels. Great care was taken to preserve the splenic vessels to ensure viability of the spleen. Once the dissection had been carried out to the right of the superior mesenteric vessels, attention was turned to the uncinate process which projects posterior to the superior mesenteric vein. Resection of the uncinate process was regarded as an essential step in the operative procedure.
After positively defining the course of the common bile duct, the pancreas to the left of the common duct and most of the gland within the concavity of the duodenum was excised. The main pancreatic duct was occasionally identified and ligated. The only pancreatic tissue remaining consisted of that part of the gland between the duodenum and the common bile duct and a sliver of tissue on the medial wall of the second part of the duodenum. This represented approximately 5% of the total volume of pancreatic tissue (fig 3) . Bleeding from the raw surface of the gland was meticulously controlled and the wound was closed with a suction drain to the pancreatic bed.
Results
There was no mortality after the 95% pancreatectomy. One patient had a slightly lesser resection due to the presence of pancreatitis and fibrosis. Hypoglycaemia recurred posto- With greater awareness of the disease, the diagnosis of nesidioblastosis should be suspected early and confirmed within a few days of birth. Insulin release normally falls as the blood glucose concentration decreases. 48 During severe hypoglycaemia insulin concentrations should be undetectable. Low plasma concentrations of free fatty acids and blood ketones simultaneously support the diagnosis of hyperinsulinism as insulin inhibits lipolysis and hence production of ketone bodies. 49 The absence of ketone bodies as an alternative energy source for cerebral function during hypoglycaemia may explain the high incidence of cerebral damage in these infants. The excess insulin also directs glucose to hepatic glycogen synthesis, probably one factor responsible for the hepatomegaly. The anabolic effect of insulin is also responsible for the high birth weight of some infants.
Trhough the diagnosis should always be confirmed by measuring plasma insulin, alternative and rapid methods of diagnosis are helpful. The glucose infusion rate, necessary to maintain normoglycaemia, should be calculated. Glucose infusion rates greater than 10 mg/kg/minute in absence of hyperglycaemia or glycosuria are diagnostic of hyperinsulinism (glucose production in the normal newborn is 5-8 mg/kg! minute).}5 All our patients required glucose infusion rates of between 10-25 mg/kg/minute. Diazoxide has been the most widely used drug, inducing hyperglycaemia by mobilising glucagon, stimulating catecholamine secretion, and directly inhibiting insulin release. However, fluid retention is common and three patients developed cardiac failure that responded rapidly to antifailure treatment. Glucagon and prednisolone have been used with varying degrees of success. Somatostatin or a long acting analogue is now the drug of choice and particularly useful in the preoperative preparation of the infant who develops cardiovascular problems from fluid overload and diazoxide treatment. Because somatostatin inhibits not only insulin release but also adrenocorticotrophic hormone and glucagon secretion its use should be combined with glucagon5' and possibly with cortisol.
Tolerance to somatostatin may develop so that surgery is still necessary, although some patients have been given long term treatment.52
The time interval between onset of symptoms and operation reported in the literature was 5-55±1-53 months in developmentally normal children compared with 9-65±2-6 months in the mentally retarded infants.' In our series the average delay between onset of symptoms and operation was 2-2 months excluding four patients who came to surgery aged between 2-5 and 5 years. Only three patients, two of whom were referred from abroad, had established neurological deficit.
Surgery is indicated when normoglycaemia cannot be reliably maintained despite adequate dosages of glucose, diazoxide, chlorothiazide, and somatostatin. Some patients have been maintained for prolonged periods with medication, notably long term somatostatin36 but the effect on glucagon and growth hormone release remains a potential risk. They still require regular frequent high carbohydrate-containing feeds but are at risk of developing hypoglycaemia that may result in brain damage, especially during episodes of stress or intercurrent infection. In 1977, Thomas et al found that at least 50% of infants undergoing pancreatic resection were mentally retarded at the time of surgery.' The incidence of neurological damage was still around 33% in recently reviewed series. It is anticipated that with the increased awareness of the disease and the safety of surgical treatment, neurological sequelae will be prevented in the majority of patients.
Diffuse involvement of the pancreas is more common that localised lesions especially in infancy. Of 188 cases published in the literature from 1982 to 1989, 137 were in infants under one year old, while 61 occurred in older children. In infants, only 7% (10 cases) had localised lesions compared with 40% (24 cases) in the older children. Fifteen infants (11%) had mixed lesions. Limited resection for localised lesions should be reserved for the older age group as diffuse involvement commonly coexists in infants with an apparent localised lesion.
In the majority of patients surgical resection involves a subtotal pancreatectomy. The extent of the resection continues to be controversial. The original subtotal pancreatectomy described by Gross constituted a 65% resection. of the operative reports indicates that in many cases the resection was well short of that described above as an adequate 95% resection and this may account for the high recurrence rate. Only one of our patients had an unsatisfactory response to pancreatic resection and required a second resection. In retrospect, it was obvious that this infant did not have a full 95% pancreatic resection at initial surgery.
We have no experience with portal blood sampling at operation to determine the adequacy of pancreatic resection as advocated by Carcassone et a124 and Kishi et al.26 Hyperglycaemia or recurrent hypoglycaemia is common in the early postoperative period,' 30 55 but once normoglycaemia has been established for a few months there is minimal risk of subsequent late complications after surgical resection.
Awareness of the disease entity, early diagnosis, and appropriate treatment are essential if irreversible brain damage is to be prevented. A 95% pancreatectomy has proved highly effective and patients not responding to medical treatment should be referred for surgery early and not as a last resort.
